Piero Picci
#120,912
Most Influential Person Now
Researcher
Piero Picci's AcademicInfluence.com Rankings
Piero Piccicomputer-science Degrees
Computer Science
#4879
World Rank
#5150
Historical Rank
Data Mining
#83
World Rank
#83
Historical Rank
Algorithms
#160
World Rank
#162
Historical Rank
Computational Linguistics
#562
World Rank
#571
Historical Rank
Download Badge
Computer Science
Piero Picci's Degrees
- PhD Computer Science University of Milan
- Masters Artificial Intelligence University of Florence
- Bachelors Mathematics Consorzio ICoN
Similar Degrees You Can Earn
Why Is Piero Picci Influential?
(Suggest an Edit or Addition)Piero Picci's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. (2001) (642)
- Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2014) (642)
- Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (624)
- Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy (2006) (532)
- Bone Tumors: Clinical, Radiologic, and Pathologic Correlations (1989) (518)
- Ewing Sarcoma: Current Management and Future Approaches Through Collaboration. (2015) (456)
- Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2015) (425)
- Osteosarcoma (Osteogenic sarcoma) (2007) (417)
- Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. (2005) (413)
- Platelet-derived growth factors enhance proliferation of human stromal stem cells. (2003) (393)
- Chordoma of the Mobile Spine: Fifty Years of Experience (2006) (382)
- Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report. (2000) (379)
- Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome. (1995) (376)
- Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. (2017) (332)
- The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation (2014) (322)
- Synovial sarcoma (2009) (306)
- A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study. (2012) (297)
- Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors. (2005) (293)
- Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli. (2000) (292)
- Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin (1993) (292)
- Aneurysmal Bone Cyst of the Mobile Spine: Report on 41 Cases (2001) (272)
- Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy regional mapping of viable and nonviable tumor (1985) (265)
- Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival. (2003) (265)
- Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. (1994) (259)
- Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2012) (254)
- Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial. (2015) (253)
- Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (244)
- Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression (2009) (243)
- Insulin-like growth factor I receptor-mediated circuit in Ewing's sarcoma/peripheral neuroectodermal tumor: a possible therapeutic target. (1996) (238)
- Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities. (1997) (237)
- Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (230)
- Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities the istituto rizzoli experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin (1990) (230)
- Chondrosarcoma of the mobile spine: report on 22 cases. (2000) (218)
- Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (216)
- Chondrosarcoma of bone. The experience at the Istituto Ortopedico Rizzoli. (1981) (198)
- Massive Bone Allograft Reconstruction in High-Grade Osteosarcoma (2000) (196)
- Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice. (1998) (196)
- Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1 (2012) (192)
- C-myc and c-fos in Human Osteosarcoma: Prognostic Value of mRNA and Protein Expression (1998) (188)
- Chondroblastoma. A review of seventy cases. (1985) (187)
- Histological heterogeneity of Ewing’s sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support (2009) (182)
- Mesenchymal chondrosarcoma of bone and soft tissues (1983) (182)
- Genome-wide Association Study Identifies Two Susceptibility Loci for Osteosarcoma (2013) (181)
- Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities. (1993) (179)
- SV40-like sequences in human bone tumors. (1996) (173)
- Chordoma of the Mobile Spine and Sacrum: A Retrospective Analysis of a Series of Patients Surgically Treated at Two Referral Centers (2009) (166)
- Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1. (2012) (163)
- Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways (2009) (160)
- Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma (2012) (159)
- Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone (1999) (159)
- Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas: a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group. (2012) (157)
- Clinical outcome of central conventional chondrosarcoma (2012) (154)
- The treatment of osteosarcoma of the extremities: Twenty year's experience at the istituto ortopedico rizzoli (1981) (153)
- Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute. (2001) (152)
- NVP-BEZ235 as a New Therapeutic Option for Sarcomas (2010) (152)
- Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells. (2001) (150)
- Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis. (2013) (150)
- CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis. (2010) (149)
- Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (147)
- Chondromyxoid fibroma. The experience at the Istituto Ortopedico Rizzoli. (1983) (146)
- Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy. (1998) (144)
- High-dose chemotherapy in the treatment of relapsed osteosarcoma: an Italian sarcoma group study. (2002) (143)
- Osteoblastoma of the spine. (1992) (142)
- Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin. (1998) (141)
- Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group (2017) (141)
- Local recurrence and local control of non‐metastatic osteosarcoma of the extremities: A 27‐year experience in a single institution (2007) (140)
- Preclinical In vivo Study of New Insulin-Like Growth Factor-I Receptor–Specific Inhibitor in Ewing's Sarcoma (2007) (139)
- Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy. (2005) (138)
- Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone (2010) (138)
- miR‐34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo‐sensitivity and malignancy (2012) (137)
- Giant-cell tumor of bone in skeletally immature patients. (1983) (135)
- Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. (2015) (133)
- Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (131)
- Treatment and outcome of recurrent osteosarcoma: Experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy (2005) (131)
- Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling (2011) (130)
- Solid variant of aneurysmal bone cyst (1993) (127)
- Histologically verified lung metastases in benign giant cell tumours—14 cases from a single institution (2006) (127)
- Prognostic and therapeutic relevance of HER2 expression in osteosarcoma and Ewing's sarcoma. (2005) (125)
- Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome. (2009) (124)
- Aneurysmal bone cyst of the spine. (1985) (124)
- Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution. (2005) (120)
- Osteosarcoma. Low‐grade intraosseous‐type osteosarcoma, histologically resembling parosteal osteosarcoma, fibrous dysplasia, and desmoplastic fibroma (1993) (118)
- miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle control. (2013) (116)
- Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma. (2008) (114)
- The expression of ccn3(nov) gene in musculoskeletal tumors. (2002) (113)
- Expression of an IGF‐I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells (2002) (113)
- Molecular mechanisms of CD99-induced caspase-independent cell death and cell–cell adhesion in Ewing's sarcoma cells: actin and zyxin as key intracellular mediators (2004) (112)
- Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients’ bed (2013) (111)
- A randomized trial for the treatment of high-grade soft-tissue sarcomas of the extremities: preliminary observations. (1986) (111)
- Oncogene alterations in primary, recurrent, and metastatic human bone tumors (1996) (107)
- Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol. (2011) (107)
- Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cells (2002) (106)
- Survival in high-grade osteosarcoma: improvement over 21 years at a single institution. (2010) (105)
- Alteration of pRb/p16/cdk4 regulation in human osteosarcoma (1999) (105)
- Positively selected enhancer elements endow osteosarcoma cells with metastatic competence (2017) (105)
- Soft Tissue and Visceral Sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 25, pg iii102, 2014) (2015) (104)
- In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type (2005) (104)
- Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long? (2017) (103)
- Emerging drugs for high-grade osteosarcoma (2010) (103)
- High Dose Ifosfamide in Combination with High Dose Methotrexate, Adriamycin and Cisplatin in the Neoadjuvant Treatment of Extremity Osteosarcoma: Preliminary Results of an Italian Sarcoma Group/Scandinavian Sarcoma Group Pilot Study (2002) (102)
- Targeting insulin-like growth factor 1 receptor in sarcomas (2008) (101)
- Atlas of Musculoskeletal Tumors and Tumorlike Lesions (2014) (101)
- The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 Upregulation in Osteosarcoma Preclinical Models (2013) (101)
- Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma. (2020) (101)
- Value of P-glycoprotein and clinicopathologic factors as the basis for new treatment strategies in high-grade osteosarcoma of the extremities. (2003) (101)
- Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups. (2020) (100)
- Immunostaining of the p30/32MIC2 antigen and molecular detection of EWS rearrangements for the diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumor. (1996) (99)
- Prognostic significance of serum alkaline phosphatase measurements in patients with osteosarcoma treated with adjuvant or neoadjuvant chemotherapy (1993) (99)
- CD99 engagement: an effective therapeutic strategy for Ewing tumors. (2000) (98)
- Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy. (1997) (98)
- Osteosarcoma of the bones of the foot--an easily misdiagnosed malignant tumor. (1998) (97)
- 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma (2012) (97)
- The role of surgical margins in treatment of Ewing's sarcoma family tumors: experience of a single institution with 512 patients treated with adjuvant and neoadjuvant chemotherapy. (2006) (97)
- Multidrug resistance and malignancy in human osteosarcoma. (1996) (96)
- Tenosynovial giant cell tumour/pigmented villonodular synovitis: outcome of 294 patients before the era of kinase inhibitors. (2015) (94)
- Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells. (2004) (93)
- Computed tomography of pulmonary metastases from osteosarcoma: the less poor technique. A study of 51 patients with histological correlation. (2001) (89)
- Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group. (2016) (89)
- Caveolin-1 reduces osteosarcoma metastases by inhibiting c-Src activity and met signaling. (2007) (89)
- Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. (2014) (88)
- Tumor response assessment by modified Choi criteria in localized high‐risk soft tissue sarcoma treated with chemotherapy (2012) (87)
- Nonmetastatic Osteosarcoma of the Extremity: Results of a Neoadjuvant Chemotherapy Protocol (IOR/OS-3) with High-dose Methotrexate, Intraarterial or Intravenous Cisplatin, Doxorubicin, and Salvage Chemotherapy Based on Histologic Tumor Response (1999) (86)
- Metalloproteinase expression and prognosis in soft tissue sarcomas. (2001) (86)
- Corrections to "Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up". (2018) (86)
- Neoadjuvant chemotherapy for extremity osteosarcoma--preliminary results of the Rizzoli's 4th study. (1998) (85)
- A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma. (2015) (85)
- Outcome of advanced, unresectable conventional central chondrosarcoma (2014) (85)
- Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma. (2004) (84)
- Genetic characterization of mesenchymal, clear cell, and dedifferentiated chondrosarcoma (2012) (84)
- Risk factors for local recurrences after limb-salvage surgery for high-grade osteosarcoma of the extremities. (1997) (84)
- Clinical correlations of genetic changes by comparative genomic hybridization in Ewing sarcoma and related tumors. (1999) (83)
- Advances in emerging drugs for osteosarcoma (2015) (83)
- Malignancy in Giant Cell Tumor of Bone: A Review of the Literature (2019) (83)
- Redundancy of autocrine loops in human osteosarcoma cells (1999) (82)
- High Expression of Complement Component 5 (C5) at Tumor Site Associates with Superior Survival in Ewing's Sarcoma Family of Tumour Patients (2011) (81)
- C-kit receptor expression in Ewing's sarcoma: lack of prognostic value but therapeutic targeting opportunities in appropriate conditions. (2003) (78)
- The treatment of localized Ewing's sarcoma: The experience at the istituto ortopedico rizzoli in 163 cases treated with and without adjuvant chemotherapy (1982) (76)
- Neoadjuvant chemotherapy for Ewing's sarcoma of bone (1998) (76)
- EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma (2018) (75)
- Changes of the p16 gene but not the p53 gene in human chondrosarcoma tissues (2000) (75)
- Comparative genomic hybridization of low-grade central osteosarcoma. (1998) (74)
- Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone (2016) (72)
- Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors (2009) (71)
- Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (71)
- Limb sparing versus amputation in osteosarcoma. Correlation between local control, surgical margins and tumor necrosis: Istituto Rizzoli experience. (1992) (70)
- Contribution of MEK/MAPK and PI3‐K signaling pathway to the malignant behavior of Ewing's sarcoma cells: Therapeutic prospects (2004) (69)
- Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall. (2013) (68)
- CD99 acts as an oncosuppressor in osteosarcoma. (2006) (68)
- Sacral Chordoma: Long-term Outcome of a Large Series of Patients Surgically Treated at Two Reference Centers (2016) (68)
- Osteoblastoma-like osteosarcoma. The Rizzoli Institute experience. (1993) (67)
- CIC–DUX4 fusion‐positive round‐cell sarcomas of soft tissue and bone: a single‐institution morphological and molecular analysis of seven cases (2016) (67)
- The management of malignant bone tumors in children and adolescents. (1991) (66)
- Impact of IGF-I/IGF-IR circuit on the angiogenetic properties of Ewing's sarcoma cells. (2003) (66)
- Localized Ewing's sarcoma of bone: ten years' experience at the Istituto Ortopedico Rizzoli in 124 cases treated with multimodal therapy. (1985) (66)
- Fusion events lead to truncation of FOS in epithelioid hemangioma of bone (2015) (65)
- Effect of TP53 Arg72Pro and MDM2 SNP309 Polymorphisms on the Risk of High-Grade Osteosarcoma Development and Survival (2009) (65)
- Molecular diagnosis in Ewing family tumors: the Rizzoli experience--222 consecutive cases in four years. (2011) (65)
- CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity (2007) (65)
- Palliative therapy for osteosarcoma (2011) (64)
- P‐glycoprotein expression in osteosarcoma: A basis for risk‐adapted adjuvant chemotherapy (1999) (63)
- Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell lines. (2012) (63)
- Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized study. (1986) (63)
- Prognostic Value of CCN3 in Osteosarcoma (2008) (63)
- Response to high‐dose ifosfamide in patients with advanced/recurrent Ewing sarcoma (2009) (63)
- Suppression of deacetylase SIRT1 mediates tumor-suppressive NOTCH response and offers a novel treatment option in metastatic Ewing sarcoma. (2014) (62)
- Surgical treatment of giant-cell tumor of the spine. The experience at the Istituto Ortopedico Rizzoli. (1983) (60)
- Targeting CD99 in association with doxorubicin: an effective combined treatment for Ewing's sarcoma. (2006) (60)
- NG2 expression predicts the metastasis formation in soft‐tissue sarcoma patients (2009) (59)
- Effectiveness of Ecteinascidin-743 against drug-sensitive and -resistant bone tumor cells. (2002) (58)
- Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation. (2012) (58)
- Morphological and immunophenotypic features of primary and metastatic giant cell tumour of bone (2009) (57)
- NG2/CSPG4-collagen type VI interplays putatively involved in the microenvironmental control of tumour engraftment and local expansion. (2013) (57)
- Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series (2018) (57)
- May P-glycoprotein status be used to stratify high-grade osteosarcoma patients? Results from the Italian/Scandinavian Sarcoma Group 1 treatment protocol. (2006) (57)
- Seven BMPs and all their receptors are simultaneously expressed in osteosarcoma cells. (2002) (56)
- Expression of insulin-like growth factor system components in Ewing's sarcoma and their association with survival. (2011) (56)
- Clinicopathological significance of cell cycle regulation markers in a large series of genetically confirmed Ewing's Sarcoma Family of Tumors (2011) (55)
- Cytokeratin expression and distribution in adamantinoma of the long bones and osteofibrous dysplasia of tibia and fibula. An immunohistochemical study correlated to histogenesis (1994) (55)
- Expression of MDR1 and GST-pi in human soft tissue sarcomas: relation to drug resistance and biological aggressiveness. (1992) (55)
- Insulin‐like growth factor binding protein 3 as an anticancer molecule in Ewing's sarcoma (2006) (54)
- Role of MMP-9 and its tissue inhibitor TIMP-1 in human osteosarcomaFindings in 42 patients followed for 1–16 years (2004) (54)
- Gastrointestinal Stromal Tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 25, pg iii21, 2014) (2015) (54)
- The istituto rizzoli experience with small cell osteosarcoma (1989) (54)
- Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma. (1999) (54)
- Therapy for primary non‐Hodgkin's lymphoma of bone and a comparison of results with ewing's sarcoma. Ten years' experience at the Istituto Ortopedico Rizzoli (1986) (54)
- Neoadjuvant chemotherapy for osteosarcoma of the extremity. (1987) (54)
- Involvement of INK4A gene products in the pathogenesis and development of human osteosarcoma (2001) (53)
- Defining Ewing and Ewing-like small round cell tumors (SRCT): The need for molecular techniques in their categorization and differential diagnosis. A study of 200 cases. (2016) (52)
- Second Malignancy in 597 Patients With Ewing Sarcoma of Bone Treated at a Single Institution With Adjuvant and Neoadjuvant Chemotherapy Between 1972 and 1999 (2005) (52)
- Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group. (2018) (52)
- Histologic Response of High-Grade Nonmetastatic Osteosarcoma of the Extremity to Chemotherapy (2001) (51)
- Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing’s sarcoma family of tumors (ESFT) (2018) (51)
- Prognostic significance of cyclin expression in human osteosarcoma. (1998) (51)
- Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities. (1991) (51)
- Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcoma. (2008) (51)
- Identification of markers of possible prognostic value in 57 giant cell tumors of bone. (2003) (50)
- Identification of potential biomarkers for giant cell tumor of bone using comparative proteomics analysis. (2011) (50)
- Adjuvant chemotherapy for soft tissue sarcoma (2005) (50)
- Identification of common and distinctive mechanisms of resistance to different anti-IGF-IR agents in Ewing's sarcoma. (2012) (50)
- Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy The Rizzoli experience in 52 patients (2006) (49)
- Complications and surgical indications in 144 cases of nonmetastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy. (1993) (49)
- A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity. (2001) (49)
- Adjuvant and neoadjuvant chemotherapy for Ewing sarcoma family tumors in patients aged between 40 and 60 (2007) (48)
- Analysis of 12q13-15 Genes in Parosteal Osteosarcoma (2000) (48)
- Metformin as an Adjuvant Drug against Pediatric Sarcomas: Hypoxia Limits Therapeutic Effects of the Drug (2013) (48)
- The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas (2016) (47)
- Screening for potential targets for therapy in mesenchymal, clear cell, and dedifferentiated chondrosarcoma reveals Bcl-2 family members and TGFβ as potential targets. (2013) (47)
- High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial. (2018) (47)
- Corrections to "Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up". (2018) (47)
- Genetic imbalances in 67 synovial sarcomas evaluated by comparative genomic hybridization (1998) (47)
- Prognostic relevance of C‐myc gene expression in giant‐cell tumor of bone (1998) (47)
- Neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone and in osteosarcoma located in the extremities: analogies and differences between the two tumors. (1997) (47)
- Histology and grading are important prognostic factors in synovial sarcoma. (2017) (47)
- Osteoid osteoma and osteoblastoma of the talus (1986) (47)
- The many faces of pulmonary metastases of osteosarcoma: Retrospective study on 283 lesions submitted to surgery. (2015) (46)
- Symptomatic vertebral hemangioma: the treatment of 23 cases and a review of the literature. (2002) (46)
- Presence of telomerase activity in different musculoskeletal tumor histotypes and correlation with aggressiveness (2001) (46)
- Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility (2018) (46)
- Growth inhibition and sensitization to cisplatin by zoledronic acid in osteosarcoma cells. (2007) (46)
- Increased C-MYC Oncogene Expression in Ewing's Sarcoma: Correlation with Ki67 Proliferation Index (1999) (46)
- Mechanisms of gene amplification and evidence of coamplification in drug‐resistant human osteosarcoma cell lines (2009) (45)
- Primary High-Grade Osteosarcoma: Comparison Between Preadolescent and Older Patients (2005) (45)
- Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations (2019) (45)
- Prognostic and predictive role of CXCR4, IGF-1R and Ezrin expression in localized synovial sarcoma: is chemotaxis important to tumor response? (2015) (44)
- Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma. (2016) (44)
- Malignant fibrous histiocytoma of bone: analysis of genomic imbalances by comparative genomic hybridisation and C-MYC expression by immunohistochemistry. (2006) (44)
- Microdeletions in 9p21.3 induce false negative results in CDKN2A FISH analysis of Ewing sarcoma (2007) (44)
- Vascular bone tumors: a proposal of a classification based on clinicopathological, radiographic and genetic features (2012) (44)
- Osteosarcoma of the Mobile Spine (2012) (44)
- The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas. (2016) (43)
- CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity (2014) (43)
- Giant cell reparative granuloma and other giant cell lesions of the bones of the hands and feet (2004) (43)
- Treatment and prognosis for synchronous multifocal osteosarcoma in 42 patients. (2006) (43)
- Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (43)
- Radiological features of 24 periosteal chondrosarcomas (2001) (43)
- Posterior Lumbar Apophyseal Fractures (1991) (42)
- CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-κB signaling (2016) (42)
- Genomic imbalances associated with methotrexate resistance in human osteosarcoma cell lines detected by comparative genomic hybridization-based techniques. (2003) (42)
- The treatment of nonmetastatic high grade osteosarcoma of the extremity: review of the Italian Rizzoli experience. Impact on the future. (2009) (42)
- Pattern of relapse in 290 patients with nonmetastatic Ewing's sarcoma family tumors treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999. (2006) (42)
- Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients (2018) (41)
- Sarcomatous degeneration of giant cell tumours. (1986) (41)
- Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1 (2017) (41)
- Improved data normalization methods for reverse phase protein microarray analysis of complex biological samples. (2012) (40)
- Atlas Of Musculoskeletal Tumors And Tumorlike Lesions. The Rizzoli Case Archive (2013) (40)
- The importance of dose-intensity in neoadjuvant chemotherapy of osteosarcoma: a retrospective analysis of high-dose methotrexate, cisplatinum and adriamycin used preoperatively. (1990) (40)
- Second Malignant Neoplasm in Patients With Osteosarcoma of the Extremities Treated With Adjuvant and Neoadjuvant Chemotherapy (2006) (39)
- Reversal of malignant phenotype in human osteosarcoma cells transduced with the alkaline phosphatase gene. (2000) (39)
- Denosumab in patients with aneurysmal bone cysts: A case series with preliminary results (2018) (39)
- Small Cell Osteosarcoma: Clinicopathologic, Immunohistochemical, and Molecular Analysis of 36 Cases (2015) (39)
- Aneurysmal Bone Cyst and Giant Cell Tumor of the Foot (1996) (38)
- Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone. (2017) (38)
- Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis. (2018) (38)
- HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma (2017) (38)
- Malignant fibrous histiocytoma: Inherited and sporadic forms have loss of heterozygosity at chromosome bands 9p21–22—evidence for a common genetic defect (2000) (38)
- Relationship between P-glycoprotein expression and p53 status in high-grade osteosarcoma. (1999) (37)
- The t(X;6) in subungual exostosis results in transcriptional deregulation of the gene for insulin receptor substrate 4 (2011) (37)
- Difficulty distinguishing benign notochordal cell tumor from chordoma further suggests a link between them (2014) (37)
- The molecular mechanisms responsible for resistance to ET-743 (Trabectidin; Yondelis) in the Ewing's sarcoma cell line, TC-71. (2005) (36)
- Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression. (2014) (36)
- Results of a Randomized Trial for the Treatment of Localized Soft Tissue Tumors (STS) of the Extremities in Adult Patients (1988) (36)
- Ewing's sarcoma family tumours. Differences in clinicopathological characteristics at presentation between localised and metastatic tumours. (2007) (36)
- CD99 Drives Terminal Differentiation of Osteosarcoma Cells by Acting as a Spatial Regulator of ERK 1/2† (2013) (35)
- Trabectedin Efficacy in Ewing Sarcoma Is Greatly Increased by Combination with Anti-IGF Signaling Agents (2015) (35)
- Resection surgery in the treatment of vertebral tumors. (1998) (35)
- CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin (2014) (35)
- Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma (2013) (35)
- The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cells (1999) (35)
- Metastatic Patterns in Osteosarcoma (1988) (34)
- Osteosarcoma of the Extremity Metastatic at Presentation: Results Achieved in 26 Patients Treated with Combined Therapy (Primary Chemotherapy Followed by Simultaneous Resection of the Primary and Metastatic Lesions) (1992) (34)
- CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signaling (2016) (34)
- Influence of adriamycin dose in the outcome of patients with osteosarcoma treated with multidrug neoadjuvant chemotherapy: results of two sequential studies. (1993) (34)
- Altered G1 phase regulation in osteosarcoma (1997) (34)
- Proteases and interleukin-6 gene analysis in 92 giant cell tumors of bone. (2004) (34)
- Elevated TNFR1 and Serotonin in Bone Metastasis Are Correlated with Poor Survival following Bone Metastasis Diagnosis for Both Carcinoma and Sarcoma Primary Tumors (2013) (33)
- Troglitazione affects survival of human osteosarcoma cells (2002) (32)
- Phenotypic and molecular differences between giant‐cell tumour of soft tissue and its bone counterpart (2017) (32)
- Neoadjuvant Chemotherapy for Osteosarcoma of the Extremities in Preadolescent Patients: The Rizzoli Institute Experience (2008) (32)
- Identification of candidate genes involved in the reversal of malignant phenotype of osteosarcoma cells transfected with the liver/bone/kidney alkaline phosphatase gene. (2004) (32)
- Synchronous multifocal osteosarcoma: results in twelve patients treated with neoadjuvant chemotherapy and simultaneous resection of all involved bones. (1996) (32)
- Clear cell chondrosarcoma of bone. A report of 8 cases. (1991) (32)
- Surgical treatment and results of 62 patients with epithelioid hemangioendothelioma of bone (2014) (31)
- p53-Dependent Activation of microRNA-34a in Response to Etoposide-Induced DNA Damage in Osteosarcoma Cell Lines Not Impaired by Dominant Negative p53 Expression (2014) (31)
- Enchondroma vs. chondrosarcoma: a simple, easy-to-use, new magnetic resonance sign. (2013) (31)
- Epidermal growth factor receptor signalling contributes to osteoblastic stromal cell proliferation, osteoclastogenesis and disease progression in giant cell tumour of bone (2011) (31)
- Chondrosarcoma of the soft tissues. Two different sub-groups. (1991) (31)
- Primary pseudomyogenic haemangioendothelioma of bone: report of two cases (2015) (31)
- MDM2 and CDK4 expression in periosteal osteosarcoma. (2015) (31)
- Metformin inhibits growth and sensitizes osteosarcoma cell lines to cisplatin through cell cycle modulation. (2014) (31)
- Adjuvant chemotherapy for malignant fibrous histiocytoma in the femur and tibia. (1985) (31)
- Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma (2016) (31)
- Diagnostic utility of molecular investigation in extraskeletal myxoid chondrosarcoma. (2014) (30)
- Osteosarcoma of the hands and feet: a distinct clinico-pathological subgroup (2012) (30)
- Prognostic relevance of CCN3 in Ewing sarcoma. (2009) (30)
- Imaging of hibernomas: A retrospective study on twelve cases (2011) (30)
- Aneurysmal bone cyst and giant cell tumor of the foot. (1997) (30)
- Changing pattern of relapse in osteosarcoma of the extremities treated with adjuvant and neoadjuvant chemotherapy. (1995) (30)
- Alpha-tocopheryl succinate alters cell cycle distribution sensitising human osteosarcoma cells to methotrexate-induced apoptosis. (2006) (29)
- Effectiveness of Type I interferons in the treatment of multidrug resistant osteosarcoma cells. (2004) (29)
- Telangiectatic osteosarcoma: a review of 87 cases (2016) (29)
- MicroRNA expression profiles in metastatic and non-metastatic giant cell tumor of bone. (2013) (29)
- Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss) (2014) (29)
- Osteoid osteoma and osteoblastoma of the talus. A report of 40 cases. (1986) (29)
- Prognostic role of nuclear factor/IB and bone remodeling proteins in metastatic giant cell tumor of bone: A retrospective study (2015) (29)
- Predictive Factors of Histologic Response to Primary Chemotherapy in Patients With Ewing Sarcoma (2007) (29)
- Activation of metalloproteinases-2 and -9 by interleukin-1alpha in S100A4-positive liposarcoma cell line: correlation with cell invasiveness. (2004) (29)
- Alpha-tocopheryl succinate induces cytostasis and apoptosis in osteosarcoma cells: the role of E2F1. (2005) (29)
- Osteosarcoma in blood relatives. (2001) (29)
- Biological indicators of prognosis in Ewing's sarcoma: An emerging role for lectin galactoside‐binding soluble 3 binding protein (LGALS3BP) (2010) (29)
- Genetic and molecular alterations in rhabdomyosarcoma: mRNA overexpression of MCL1 and MAP2K4 genes. (2009) (28)
- Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight? (2017) (28)
- The incidental skeletal lesion: ignore or explore? (2009) (28)
- Murine model for skeletal metastases of Ewing's sarcoma (2000) (27)
- Detection of circulating tumor cells in liquid biopsy from Ewing sarcoma patients (2018) (27)
- Neoadjuvant Chemotherapy for High Grade Malignant Fibrous Histiocytoma of Bone (1998) (27)
- A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy (2018) (27)
- Array comparative genomic hybridization reveals frequent alterations of G1/S checkpoint genes in undifferentiated pleomorphic sarcoma of bone (2011) (27)
- CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients. (2015) (27)
- Solitary fibrous tumors of the soft tissues: imaging features with histopathologic correlations (2013) (26)
- Tumours of the patella (2004) (26)
- Targeting polo-like kinase 1 by NMS-P937 in osteosarcoma cell lines inhibits tumor cell growth and partially overcomes drug resistance (2014) (26)
- MRP1 Overexpression Determines Poor Prognosis in Prospectively Treated Patients with Localized High-Risk Soft Tissue Sarcoma of Limbs and Trunk Wall: An ISG/GEIS Study (2013) (26)
- Centrosome abnormalities in giant cell tumour of bone: possible association with chromosomal instability (2010) (26)
- Tissue and serum loss of metalloproteinase inhibitors in high grade soft tissue sarcomas. (2003) (25)
- Prognostic Value of Serum Alkaline Phosphatase in Osteosarcoma (1987) (25)
- Dedifferentiated peripheral chondrosarcomas (1989) (25)
- Angiogenesis in lipoma: An experimental study in the chick embryo chorioallantoic membrane. (1999) (25)
- Preclinical Effectiveness of Selective Inhibitor of IRS-1/2 NT157 in Osteosarcoma Cell Lines (2015) (25)
- Genome‐wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients (2018) (25)
- Dedifferentiated chondrosarcoma. (1995) (25)
- Tissue and serum IGFBP7 protein as biomarker in high-grade soft tissue sarcoma. (2015) (25)
- Methotrexate serum concentration and histological response to multiagent primary chemotherapy for osteosarcoma of the limbs. (1996) (25)
- Fibrosarcomatous changes and expression of CD34+ and apolipoprotein-D in dermatofibrosarcoma protuberans (2012) (25)
- Synovial chondrosarcoma: report of two cases and literature review. (2009) (25)
- 153Samarium-EDTMP administration followed by hematopoietic stem cell support for bone metastases in osteosarcoma patients. (2012) (25)
- Secondary tumors in bone sarcomas after treatment with chemotherapy. (1999) (25)
- Targeting Glutathione-S Transferase Enzymes in Musculoskeletal Sarcomas: A Promising Therapeutic Strategy (2011) (25)
- Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types (2015) (24)
- Differential gene expression in classic giant cell tumours of bone: Tenascin C as biological risk factor for local relapses and metastases (2010) (24)
- Sacral osteoid osteoma and osteoblastoma: a report of 13 cases (2004) (24)
- Epithelial marker expression does not rule out a diagnosis of Ewing’s sarcoma family of tumours (2011) (24)
- Osteoblastoma‐like osteosarcoma: high‐grade or low‐grade osteosarcoma? (2018) (24)
- Genetic analysis of fibrosarcoma of bone, a rare tumour entity closely related to osteosarcoma and malignant fibrous histiocytoma of bone. (2004) (24)
- Significant association between human osteosarcoma and simian virus 40 (2015) (23)
- Extraskeletal Myxoid Chondrosarcoma with Molecularly Confirmed Diagnosis: A Multicenter Retrospective Study Within the Italian Sarcoma Group (2020) (23)
- Chondrosarcoma of the hand and foot. (1990) (23)
- Neoadjuvant chemotherapy for osteosarcoma of the extremities in patients aged 41–60 years (2007) (23)
- Mapping protein signal pathway interaction in sarcoma bone metastasis: linkage between rank, metalloproteinases turnover and growth factor signaling pathways (2013) (23)
- Imaging of bone tumors for the musculoskeletal oncologic surgeon. (2013) (23)
- sarcomaFull-dose neoadjuvant anthracycline + ifosfamide chemotherapy is associated with a relapse free survival (RFS) and overall survival (OS) benefit in localized high-risk adult soft tissue sarcomas (STS) of the extremities and trunk wall: Interim analysis of a prospective randomized trial (2016) (22)
- Epithelial cell adhesion molecules and epithelial mesenchymal transition (EMT) markers in Ewing's sarcoma family of tumors (ESFTs). Do they offer any prognostic significance? (2012) (22)
- Predictive factors of histological response to primary chemotherapy in Ewing's sarcoma. (1998) (22)
- Primary Angiosarcoma of Bone: A Retrospective Analysis of 60 Patients From 2 Institutions (2014) (22)
- Prognostic significance of serum lactate dehydrogenase in patients with osteosarcoma of the extremities. (1994) (22)
- Differentially expressed genes in multidrug resistant variants of U-2 OS human osteosarcoma cells. (2004) (22)
- Identification of EWS/FLI‐1 transcripts in giant‐cell tumor of bone (2000) (22)
- Neoadjuvant chemotherapy in high‐risk soft tissue sarcomas: A Sarculator‐based risk stratification analysis of the ISG‐STS 1001 randomized trial (2021) (22)
- Receptor tyrosine kinase pathway analysis sheds light on similarities between clear‐cell sarcoma and metastatic melanoma (2012) (22)
- Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation (2019) (22)
- Soft Tissue Tumors Rarely Presenting Primary in Bone; Diagnostic Pitfalls. (2017) (21)
- Periacetabular pelvic resections (1987) (21)
- Xg expression in Ewing's sarcoma is of prognostic value and contributes to tumor invasiveness. (2010) (21)
- The sacral chordoma margin. (2020) (21)
- NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas (2019) (21)
- Parosteal osteosarcoma dedifferentiating into telangiectatic osteosarcoma: importance of lytic changes and fluid cavities at imaging (2009) (21)
- Vincristine, Doxorubicin, Cyclophosfamide, Actinomycin D, Ifosfamide, and Etoposide in Adult and Pediatric Patients with Nonmetastatic Ewing Sarcoma. Final Results of a Monoinstitutional Study (2010) (21)
- Primary chemotherapy and delayed surgery for non-metastatic telangiectatic osteosarcoma of the extremities. Results in 28 patients. (1994) (21)
- Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation. (2012) (21)
- Extra-axial chordoma: a clinicopathologic analysis of six cases (2018) (20)
- Aneurysmal Bone Cyst of the Mobile Spine (2000) (20)
- Adjuvant chemotherapy with six drugs (adriamycin, methotrexate, cisplatinum, bleomycin, cyclophosphamide and dactinomycin) for non-metastatic high grade osteosarcoma of the extremities. Results of 32 patients and comparison to 127 patients concomitantly treated with the same drugs in a neoadjuvant f (1988) (20)
- Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells (2016) (20)
- Primary non-Hodgkin's lymphoma of bone: results in 15 patients treated by radiotherapy combined with systemic chemotherapy. (1982) (20)
- Front‐line window therapy with cisplatin in patients with primary disseminated Ewing sarcoma: A study by the Associazione Italiana di Ematologia ed Oncologia Pediatrica and Italian Sarcoma Group (2017) (20)
- Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 is a Novel Post-Transcriptional Regulator of Ewing Sarcoma Malignancy (2018) (20)
- Excision repair cross‐complementation group 1 protein expression predicts survival in patients with high‐grade, non‐metastatic osteosarcoma treated with neoadjuvant chemotherapy (2015) (20)
- Recurring osteoblastoma initially presenting as a typical osteoid osteoma (2004) (19)
- Late sarcoma development after curettage and bone grafting of benign bone tumors. (2011) (19)
- Presence and expression of the Simian virus‐40 genome in human giant cell tumors of bone (2000) (19)
- Chondroblastoma-like osteosarcoma. (1999) (19)
- Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities: the recent experience at the Rizzoli Institute. (1993) (19)
- Primary lymphoma of bone: long term results in patients treated with vincristine--adriamycin--cyclophosphamide and local radiation. (1991) (19)
- Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patients. (2016) (19)
- Prognostic Impact of Reduced Connexin43 Expression and Gap Junction Coupling of Neoplastic Stromal Cells in Giant Cell Tumor of Bone (2015) (19)
- Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases. (2007) (19)
- Immunohistochemical analysis of NKX2.2, ETV4, and BCOR in a large series of genetically confirmed Ewing sarcoma family of tumors. (2017) (19)
- Intra-arterial versus intravenous cisplatinum (in addition to systemic Adriamycin and high dose methotrexate) in the neoadjuvant treatment of osteosarcoma of the extremities. results of a randomized study. (1996) (19)
- High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series (2020) (18)
- The effectiveness of chemotherapy in localized malignant fibrous histiocytoma (MFH) of bone: the Rizzoli Institute experience with 66 patients treated with surgery alone or surgery + adjuvant or neoadjuvant chemotherapy. (1988) (18)
- Galectin-1 (GAL-1) expression is a useful tool to differentiate between small cell osteosarcoma and Ewing sarcoma (2013) (18)
- Generation of human single-chain antibody to the CD99 cell surface determinant specifically recognizing Ewing's sarcoma tumor cells. (2013) (18)
- Comparison of the Outcome of Conventional Osteosarcoma at Two Specialist International Orthopaedic Oncology Centres (2003) (18)
- Clear cell chondrosarcoma of bone (2004) (18)
- No correlation between methotrexate serum level and histologic response in the pre-operative treatment of extremity osteosarcoma (2006) (18)
- Effect of intra-arterial versus intravenous cisplatin in addition to systemic adriamycin and high-dose methotrexate on histologic tumor response of osteosarcoma of the extremities. (1992) (18)
- Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis (2014) (18)
- PAROSTEAL osteosarcoma: a monocentric retrospective analysis of 195 patients. (2019) (18)
- Osteosarcoma follow-up: chest X-ray or computed tomography? (2017) (17)
- Neoadjuvant Chemotherapy for Osteosarcoma — Results of a Prospective Study (1988) (17)
- Frequent deletion of CDKN2A and recurrent coamplification of KIT, PDGFRA, and KDR in fibrosarcoma of bone—An array comparative genomic hybridization study (2010) (17)
- p16 expression as a prognostic and predictive marker in high-grade localized osteosarcoma of the extremities: an analysis of 357 cases. (2016) (17)
- Margins, necrosis and local recurrence after conservative surgery in osteosarcoma. (1990) (17)
- Treatment Recommendations for Osteosarcoma and Adult Soft Tissue Sarcomas (2012) (17)
- Solitary Plasmacytoma of the Vertebral Column. A Report of 15 Cases (1982) (17)
- Primary extraskeletal myxoid chondrosarcoma of bone: Report of three cases and review of the literature. (2017) (16)
- Integrated approaches to miRNAs target definition: time-series analysis in an osteosarcoma differentiative model (2015) (16)
- Prognostic Significance of Nuclear Accumulation of c-myc and mdm2 Proteins in Synovial Sarcoma of the Extremities (2000) (16)
- An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas (2014) (16)
- Adhesion molecules in high-grade soft tissue sarcomas: correlation to clinical outcome. (1998) (16)
- miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma (2017) (16)
- Sclerosing epithelioid fibrosarcoma of the thigh: report of two cases with synchronous bone metastases (2015) (15)
- DNA copy number amplifications in sarcomas with homogeneously staining regions and double minutes. (2001) (15)
- Prognostic value of P-glycoprotein in high-grade osteosarcoma. (2007) (15)
- miR-196a expression in human and canine osteosarcomas: a comparative study. (2015) (15)
- Copy number alterations and neoplasia‐specific mutations in MELK, PDCD1LG2, TLN1, and PAX5 at 9p in different neoplasias (2014) (15)
- Identification of novel candidate circulating biomarkers for malignant soft tissue sarcomas: Correlation with metastatic progression (2016) (15)
- Medullary involvement in parosteal osteosarcoma. A case report. (1987) (15)
- Gene expression profiling of giant cell tumor of bone reveals downregulation of extracellular matrix components decorin and lumican associated with lung metastasis (2014) (15)
- Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of IGF1R (2018) (15)
- Neoadjuvant Chemotherapy for Osteosarcoma (1989) (14)
- High-grade focal areas in low-grade central osteosarcoma: high-grade or still low-grade osteosarcoma? (2015) (14)
- Hemorrhagic synovial lumbar cyst: a case report and review of the literature. (1999) (14)
- Bone marrow biopsy in the initial staging of Ewing sarcoma: Experience from a single institution (2019) (14)
- Simultaneous Paired Analysis of Numerical Chromosomal Aberrations and DNA Content in Osteosarcoma (2001) (14)
- The Mazabraud syndrome: case report and review of the literature. (1987) (14)
- Primary Chemotherapy and Delayed Surgery for Malignant Fibrous Histiocytoma of Bone in the Extremity (1990) (14)
- Neoadjuvant chemotherapy for osteosarcoma of the extremities. Good response of the primary tumor after preoperative chemotherapy with high-dose methotrexate followed by cisplatinum and adriamycin. Preliminary results. (1988) (14)
- The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24–25, 2015. Workshop Report (2016) (14)
- Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab (2021) (14)
- Pharmacogenomics of genes involved in antifolate drug response and toxicity in osteosarcoma (2017) (14)
- Quantification of the Heterogeneity of Prognostic Cellular Biomarkers in Ewing Sarcoma Using Automated Image and Random Survival Forest Analysis (2014) (14)
- The role of surgical therapy in patients with nonmetastatic Ewing's sarcoma of the limbs. (1993) (14)
- Evaluation of p16 and Id1 status and endogenous reference genes in human chondrosarcoma by real-time PCR. (2005) (14)
- Feasibility of high-dose chemotherapy and autologous peripheral blood stem cell transplantation in children with high grade osteosarcoma. (1998) (14)
- [Ewing's sarcoma of the bone. Anatomoclinical study of 424 cases]. (1992) (14)
- Full-lung tomograms and bone scanning in the initial work-up of patients with osteogenic sarcoma. A review of 126 cases. (1982) (14)
- Evaluation of the molecular mechanisms involved in the gain of function of a Li‐Fraumeni TP53 Mutation (2005) (14)
- Identification of genetic variants in pharmacokinetic genes associated with Ewing Sarcoma treatment outcome. (2016) (13)
- No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies. (1993) (13)
- Neoadjuvant chemotherapy for localized Ewing sarcoma of bone : experience at the Istituto Ortopedico Rizzoli (1991) (13)
- Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group (2021) (13)
- Prognostic role of XTP1/DEPDC1B and SDP35/DEPDC1A in high grade soft-tissue sarcomas. (2018) (13)
- IMMUNOSARC: a collaborative Spanish (GEIS) and Italian (ISG) sarcoma groups phase I/II trial of sunitinib and nivolumab in advanced soft tissue and bone sarcoma: Results from the phase II part, bone sarcoma cohort. (2020) (13)
- Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas (2014) (13)
- Nonmetastatic osteosarcoma of the extremity: Neoadjuvant chemotherapy with methotrexate (MTX), cisplatin (CDP), doxorubicin (ADM) with or without ifosfamide (IFO)--A randomized trial of the Italian Sarcoma Group (ISG/OS-1). (2010) (13)
- Diagnosis of Musculoskeletal Tumors and Tumor-like Conditions: Clinical, Radiological and Histological Correlations - The Rizzoli Case Archive (2020) (13)
- [Surgical treatment of pulmonary metastases of osteosarcoma. Apropos of 206 operated cases]. (1999) (13)
- Intracortical osteosarcoma: Rare entity or early manifestation of classical osteosarcoma? (2004) (12)
- Radiological study of 12 high-grade surface osteosarcomas (2001) (12)
- Immunoreactivity using anti-ERG monoclonal antibodies in sarcomas is influenced by clone selection. (2014) (12)
- Genetic testing for high-grade osteosarcoma: a guide for future tailored treatments? (2018) (12)
- Ewing Sarcoma in Patients over 40 Years of Age: A Prospective Analysis of 31 Patients Treated at a Single Institution (2016) (12)
- Metachronous pulmonary metastases resection in patients with Ewing's sarcoma initially treated with adjuvant or neoadjuvant chemotherapy. (1995) (12)
- Unicameral and aneurysmal bone cysts. (1986) (12)
- Osteosarcoma arising in an exostosis: CT and MR imaging. (2001) (12)
- Osteosarcoma of the pelvis: a monoinstitutional experience in patients younger than 41 years. (2012) (12)
- The effect of intra-arterial versus intravenous cisplatinum in the neoadjuvant treatment of osteosarcoma of the limbs: the experience at the Rizzoli Institute. (1996) (11)
- Fibrocartilaginous mesenchymoma of bone: a single‐institution experience with molecular investigations and a review of the literature (2017) (11)
- Intraosseous papillary intralymphatic angioendothelioma (PILA): one new case and review of the literature (2018) (11)
- Synovial chondromatosis of the shoulder. A review of the literature and description of a clinical case. (1997) (11)
- Targeting ROCK2 rather than ROCK1 inhibits Ewing sarcoma malignancy (2017) (11)
- Adjuvant and neo-adjuvant chemotherapy for Ewing's sarcoma family tumors and osteosarcoma of the extremity: further outcome for patients event-free survivors 5 years from the beginning of treatment. (2007) (11)
- Intramuscular hemangioma in infancy: diagnostic and therapeutic considerations. (1989) (10)
- [Osteosarcoma of the extremities metastatic at presentation. Results obtained with primary chemotherapy followed by simultaneous resection of the primary and metastatic lesion]. (1993) (10)
- Vertebral osteosarcoma. (1988) (10)
- Changes in p14ARF do not play a primary role in human chondrosarcoma tissues (2001) (10)
- Adjuvant chemotherapy for extremity soft-tissue sarcomas in adults (2000) (10)
- miR‑494.3p expression in synovial sarcoma: Role of CXCR4 as a potential target gene. (2018) (10)
- Neoadjuvant chemotherapy for the treatment of osteosarcoma of the extremities: excellent response of the primary tumor to preoperative treatment with methotrexate, cisplatin, adriamycin, and ifosfamide. Preliminary results. (1995) (10)
- Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study. (2021) (10)
- The distinct clinical features of giant cell tumor of bone in pagetic and non-pagetic patients are associated with genetic, biochemical and histological differences. (2017) (10)
- Altered expression of urokinase-type plasminogen activator and plasminogen activator inhibitor in high-risk soft tissue sarcomas. (2007) (10)
- Expression of G1 phase regulators in MG-63 osteosarcoma cell line. (1999) (10)
- Paediatric chondrosarcomas: a retrospective review of 17 cases (2016) (9)
- How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation? (2020) (9)
- Case report 489: Hibernoma of left thigh. (1988) (9)
- Alveolar soft part sarcoma (1996) (9)
- Alliance Against Cancer, the network of Italian cancer centers bridging research and care (2015) (9)
- Giant Cell Tumor of Bone: A Model for the in Vitro Human Osteoclast Characterization (1989) (9)
- Targeting GSTP 1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and-resistant human osteosarcoma cell lines w z (2011) (9)
- Targeted therapies in bone sarcomas. (2009) (9)
- Current understanding of pharmacogenetic implications of DNA damaging drugs used in osteosarcoma treatment (2019) (9)
- Spontaneous healing of an osteochondroma fracture. (2015) (9)
- Multicentric osteosarcoma. Report of 5 cases. (1991) (8)
- Non-metastatic Ewing's sarcoma: results in 98 patients treated with neoadjuvant chemotherapy. (1991) (8)
- CD99 polymorphisms significantly influence the probability to develop Ewing sarcoma in earlier age and patient disease progression (2016) (8)
- The treatment of localized osteosarcoma of the extremities: the Italian experience. Studies of the National Research Council. (1992) (8)
- Telangiectatic osteogenic sarcoma of the extremities. Results in 17 patients treated with neoadjuvant chemotherapy. (1991) (8)
- Response to melphalan in up-front investigational window therapy for patients with metastatic Ewing's family tumours. (2007) (8)
- Correlation between apoptosis and TP53 status in osteosarcoma. (1998) (8)
- Staging, Therapy and Prognosis of Primary Non-Hodgkin's Lymphoma of Bone and a Comparison of Results with Localized Ewing's Sarcoma: Ten Years Experience at the Istituto Ortopedico Rizzoli (1985) (8)
- Phase 2 study for nonmetastatic extremity high‐grade osteosarcoma in pediatric and adolescent and young adult patients with a risk‐adapted strategy based on ABCB1/P‐glycoprotein expression: An Italian Sarcoma Group trial (ISG/OS‐2) (2022) (8)
- Osteosarcoma of the Pelvis: A Monoinstitutional Experience in Patients Younger than 41 Years (2012) (8)
- Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: is a good response to preoperative treatment an indication to reduce postoperative chemotherapy? (1986) (7)
- A European treatment protocol for bone sarcoma in patients older than 40 years. (2009) (7)
- Evidence for and implications of SV40-like sequences in human mesotheliomas and osteosarcomas. (1998) (7)
- Limb salvage in osteogenic sarcoma of extremities: a new therapeutic approach associating infusion and hyperthermic antiblastic perfusion (1987) (7)
- CD 99 triggering induces methuosis of Ewing sarcoma cells through IGF-1 R / RAS / Rac 1 signaling (2018) (7)
- Osteosarcoma and other cancers of bone (1992) (7)
- Osteoid osteoma of the elbow. A study of twelve cases. (1989) (7)
- [Percutaneous computed tomography-guided biopsy in spinal diseases]. (1994) (7)
- Non-metastatic Ewing's family tumors: High-dose chemotherapy with stem cell rescue in poor responder patients. Preliminary results of the Italian/Scandinavian ISG/SSG III protocol (2007) (7)
- Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: Final results of a randomized clinical trial from the Italian Sarcoma Group, the Spanish Sarcoma Group (GEIS), the French Sarcoma Group (FSG), and the Polish Sarcoma Group (PSG). (2019) (7)
- Case report 489 (2004) (7)
- Comprar Atlas Of Musculoskeletal Tumors And Tumorlike Lesions. The Rizzoli Case Archive | Picci, P. | 9783319017471 | Springer (2013) (7)
- Case report 629 (2004) (7)
- Inferior survival for patients with malignant peripheral nerve sheath tumors defined by aberrant TP53 (2018) (7)
- Design and construction of a new human naïve single-chain fragment variable antibody library, IORISS1. (2016) (7)
- Neoadjuvant chemotherapy for osteosarcoma of the extremities: the Rizzoli Institute experience. (1990) (6)
- Induction of HLA class II antigens in osteosarcoma cells by interferons and tumor necrosis factor alpha. (1992) (6)
- Circulating Candidate Biomarkers in Giant Cell Tumors of Bone (2018) (6)
- 4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a promising new candidate for chemotherapeutic treatment of osteosarcoma patients. (2005) (6)
- In situ cell cycle analysis in giant cell tumor of bone reveals patients with elevated risk of reduced progression-free survival. (2019) (6)
- Osteosarcoma of the Sternum: Two Case Reports (2002) (6)
- Angiosarcoma of bone: a retrospective study of the European Musculoskeletal Oncology Society (EMSOS) (2020) (6)
- Value of immunohistochemical detection of noncollagenous proteins of bone for the diagnosis of bone tumours. (1996) (6)
- Sequencing IDH1/2 glioma mutation hotspots in gliomas and malignant peripheral nerve sheath tumors. (2014) (6)
- Neoadjuvant chemotherapy for localized osteosarcoma of the extremities. Experience related to 103 cases treated between March 83 - March 86 (1987) (6)
- The role of surgery in the treatment of localized Ewing's sarcoma. (1990) (6)
- Sinusoidal obstruction syndrome/veno-occlusive disease after high-dose intravenous busulfan/melphalan conditioning therapy in high-risk Ewing Sarcoma (2018) (6)
- Regression of metastatic osteosarcoma following non-myeloablative stem cell transplantation. A case report. (2003) (6)
- EXTRASKELETAL OSTEOSARCOMA: CLINICO-PATHOLOGIC FEATURES AND RESULTS OF MULTIMODAL MANAGEMENT (2010) (6)
- A histomorphologic study of explants of massive allografts: preliminary results. (1995) (6)
- Modular Endoprosthesis for Humerus and Tikhoff-Linberg Resection (1987) (5)
- Unlocking bone for proteomic analysis and FISH (2019) (5)
- Neuroendocrine differentiation in a large series of genetically-confirmed Ewing's sarcoma family tumor: Does it provide any diagnostic or prognostic information? (2021) (5)
- Pigmented villonodular synovitis of the hip. Study of 9 cases. (1983) (5)
- The distinct clinical features of giant cell tumor of bone in pagetic and non-pagetic patients are associated with genetic, biochemical and histological differences (2017) (5)
- A phase 1b trial with the combination of trabectedin and olaparib in relapsed patients (pts) with advanced and unresectable bone and soft tissue sarcomas (BSTS): An Italian Sarcoma Group (ISG) study. (2016) (5)
- Case report 437 (2004) (5)
- [Rare localizations of osteosarcoma: the epiphyses and tarsus osseus]. (1986) (5)
- Inflammation and infiltration: can the radiologist draw a line? MRI versus CT to accurately assess medullary involvement in parosteal osteosarcoma (2020) (5)
- Recovery of stromal stem cells in bone sarcoma patients after chemotherapy: implication for cell-based therapy in bone defect reconstruction. (2003) (5)
- [The epiphyseal involvement of metaphyseal bone sarcomas in patients with fertile growth plates. A magnetic resonance assessment]. (1994) (5)
- The role of surgery in the local treatment of Ewing's sarcoma of the extremities. (1990) (5)
- Serum Antibodies Against Simian Virus 40 Large T Antigen, the Viral Oncoprotein, in Osteosarcoma Patients (2018) (5)
- Osteoid Osteoma of the Lateral Cuneiform Bone (1994) (5)
- [The surgery of pulmonary metastases. The surgical indications and technical aspects of lung resections for metastases]. (1994) (5)
- [Treatment of metastatic osteosarcoma with verapamil, cyclosporine and chemotherapy. A case report]. (1995) (5)
- Case report 629: Osseous hydatidosis. (1990) (5)
- [Neoadjuvant chemotherapy in malignant fibrous histiocytoma of the limbs: 10 years of experience (1983-1992) at the Rizzoli Orthopedic Institute]. (1996) (5)
- How a Clinical Trial Unit can improve independent clinical research in rare tumors: the Italian Sarcoma Group experience (2017) (4)
- Telangiectatic or Hemorrhagic Osteosarcoma of Bone: A Clinicopathologic Study of 41 Patients at the Rizzoli Institute (1989) (4)
- Abstract 589: Expression levels of ABCA6 or ABCA7 predict primary Ewing sarcoma progression at diagnosis (2015) (4)
- Front-Line Window Therapy with Temozolomide and Irinotecan in Patients with Primary Disseminated Multifocal Ewing Sarcoma: Results of the ISG/AIEOP EW-2 Study (2021) (4)
- Osteosarcoma: What did we learn from the paediatric experience for adolescents and young adults? (2007) (4)
- Clinical Significance of Tumor Protein D52 Immunostaining in a Large Series of Ewing's Sarcoma Family of Tumors (2011) (4)
- Primary chemotherapy and delayed surgery for osteosarcoma of the extremities with synchronous metastases. (1992) (4)
- Combined treatment in osteosarcoma (1983) (4)
- Osteosarcomas (OS) (2019) (4)
- A nonrandomized phase II trial of sorafenib (S) and everolimus (E) in unresectable metastatic osteosarcoma (OST) patients (pts) relapsed after standard chemotherapy. (2014) (4)
- The sarculator stratified prognosis of patients with high-risk soft tissue sarcomas (STS) of extremities and trunk wall treated with perioperative chemotherapy in a randomised controlled trial (RCT). (2017) (3)
- [Osteosarcoma: magnetic resonance imaging of the effects of preoperative chemotherapy]. (1993) (3)
- Frequency and prognostic value of HLA antigens in osteosarcoma patients. (2008) (3)
- Staging and treatment of primary tumors of the spine (1999) (3)
- Case report 437: Solitary (unicameral, simple) bone cyst of the scapula. (1987) (3)
- Surgical Outcome and Oncological Survival of Osteofibrous Dysplasia-Like and Classic Adamantinomas: An International Multicenter Study of 318 Cases. (2020) (3)
- Characterization of a novel round cell tumor of bone continuous cell line with neuroectodermal features. (1990) (3)
- Neoadjuvant chemotherapy for the treatment of osteosarcoma of the limbs. Preliminary results in 100 patients treated preoperatively with high doses of methotrexate i.v. followed by cisplatin (i.a.) and adriamycin. (1991) (3)
- Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial) (2022) (3)
- Surgery of osteosarcoma of the extremities: indications and complications in the recent experience at the Istituto Ortopedico Rizzoli. (1993) (3)
- Resection and temporary stabilization with Kuntscher rod (or plate, or external fixation) and acrylic cement (1983) (3)
- The prognostic value of serum alkaline phosphatase in osteosarcoma of the limbs. (1992) (3)
- Annual Scientific Meeting Abstracts of the European Society of Musculoskeletal Radiology (ESSR) 2018, Amsterdam, The Netherlands (2018) (3)
- Histological response to neoadjuvant chemotherapy in localized Ewing sarcoma of the bone: A retrospective analysis of available scoring tools. (2021) (3)
- Correction: The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation (2014) (3)
- Two Episodes of Ifosfamide-Related Neurotoxicity in the Same Patient following Different Schedules and Doses of the Drug. A Case Report (2000) (3)
- Diagnostic approach to bone tumours. (1986) (3)
- Surgical Outcome and Oncological Survival of Osteofibrous Dysplasia-Like and Classic Adamantinomas: An International Multicenter Study of 318 Cases. (2020) (3)
- Giant notochordal rests misdiagnosed and treated as chordomas. A retrospective clinical, radiological and histologic study of four cases (2008) (3)
- High dose ifosfamide in metastatic high-grade osteosarcoma, after failure of standard multimodal chemotherapy. (2015) (3)
- Imaging , Diagnosis , Prognosis Effect of TP 53 Arg 72 Pro and MDM 2 SNP 309 Polymorphisms on the Risk of High-Grade Osteosarcoma Development and Survival (2009) (3)
- Molecular alterations of monophasic synovial sarcoma: loss of chromosome 3p does not alter RASSF1 and MLH1 transcriptional activity. (2006) (3)
- The hypothetical change in the natural history of osteosarcoma: The experience at the Bone Tumor Center of the Istituto Ortopedico Rizzoli (1982) (3)
- Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial (2021) (2)
- Workshop Report on the European Bone Sarcoma Networking Meeting: Integration of Clinical Trials with Tumor Biology. (2011) (2)
- Case report 489 (2004) (2)
- Tumors of the Sacrum (2017) (2)
- Combined treatment of osteosarcoma of the limbs at an advanced stage, including hyperthermic-antiblastic perfusion. (1990) (2)
- Cell Cycle Regulatory Protein Expression in Multinucleated Giant Cells of Giant Cell Tumor of Bone: do They Proliferate? (2021) (2)
- PD1 and PDL1 expression, tumoral microenvironment (TME) characterization and clinical implication in localized osteosarcoma (2016) (2)
- Case report 301 (2004) (2)
- Evaluation of necrosis in 42 patients with osteosarcoma of the extremities treated by preoperative chemotherapy (1986) (2)
- 1625MO ABCB1/P-glycoprotein (Pgp) expression as stratification factor for treatment of patients with non metastatic extremity high grade osteosarcoma: An Italian Sarcoma Group (ISG) multicentric prospective trial (ISG/OS-2) (2020) (2)
- [Resection with preservation of the lower limb in chondrosarcoma of the pelvis]. (1985) (2)
- Maintenance therapy with oral cyclophosphamide plus celecoxib in patients with metastatic Ewing sarcoma: Results of the Italian Sarcoma Group/AIEOP EW-2 study. (2020) (2)
- Epidemiology of Bone Lesions (2019) (2)
- High-dose chemotherapy with autologous stem cell transplantation for relapsed Ewing's sarcoma. (2016) (2)
- Classification of Primary Bone Lesions (2019) (2)
- Abstract 3201: Insulin-like growth factor 2 (IGF-2) mRNA binding protein 3 predicts poor prognosis and promotes cell proliferation in Ewing sarcoma (2016) (2)
- Adjuvant Multiple Drug Chemotherapy for Osteosarcoma of the Extremity: A 6 Year Report (1979) (2)
- Gemcitibine (G) and docetaxel (D) in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy. (2014) (2)
- Workshop report on the 2nd Joint ENCCA/EuroSARC European bone sarcoma network meeting: integration of clinical trials with tumour biology (2014) (2)
- [Magnetic resonance for the study of osteosarcoma]. (1991) (2)
- Role of MMP-9 and its tissue inhibitor TIMP-1 in human osteosarcoma (2004) (2)
- Correction: Corrigendum: Positively selected enhancer elements endow osteosarcoma cells with metastatic competence (2018) (2)
- Synovial sarcoma: Is chemotaxis important to tumor progression? (2013) (2)
- Advances in bone metastasis management (2012) (2)
- Extraskeletal myxoid chondrosarcoma: A retrospective analysis of 69 patients with localized disease and molecularly confirmed diagnosis. (2014) (1)
- Thrombo-embolism as a complication of prosthetic replacement operations of the hip: prophylaxis with heparin at low doses. (1980) (1)
- Register of primary malignant tumors of the bone at the Rizzoli Orthopaedic Institute in Bologna. (1994) (1)
- [Nonmetastatic osteosarcoma of the limb: effects of the biopsy (frozen section with immediate surgery vs traditional biopsy with deferred surgery) on survival. Study of 195 cases treated by amputation and adjuvant chemotherapy]. (1988) (1)
- ercc1 protein expression predicts survival in patients with high-grade, non-metastatic osteosarcoma treated with neoadjuvant chemotherapy Short running title: ercc1 clinical impact in high-grade osteosarcoma (2015) (1)
- Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients’ bed (2013) (1)
- Neoadjuvant Chemotherapy for Extremity (1998) (1)
- [Angiographic evaluation of the response of osteosarcoma to neoadjuvant chemotherapy]. (1988) (1)
- Central Low-Grade Osteosarcoma (2014) (1)
- The Role of the Pathologist in the Treatment of Osteosarcoma (1988) (1)
- Epidemiology of Soft Tissue Lesions (2019) (1)
- Malignant fibrous histiocytoma arising from an exostosis in a patient affected by multiple exostoses. (1982) (1)
- An observational, multicenter, retrospective, Italian Sarcoma Group (ISG) study of trabectedin in patients with advanced soft tissue sarcoma (STS). (2018) (1)
- Case report 517 (2004) (1)
- Abstract C213: Sorafenib blocks tumor growth, angiogenesis, and metastatic potential in preclinical models of osteosarcoma through the inhibition of ERK1/2, MCL‐1, and ezrin pathways (2009) (1)
- Immune-infiltrate characterization in localized osteosarcoma patients treated within protocol ISG-OS1. (2017) (1)
- Prognostic and therapeutic targets in the Ewing's family of tumors (PROTHETS). (2006) (1)
- Survival in high-grade osteosarcoma: Improvement in a 21-year period at a single institution. (2016) (1)
- Positively Selected Enhancer Elements Endow Tumor Cells with Metastatic Competence (2017) (1)
- Osteosarcoma of the pelvis and sacrum: A retrospective analysis of 73 patients. (2011) (1)
- Autografts arthrodesis for resection of the distal femur or proximal tibia (1983) (1)
- Long-term treatment of giant cell tumors of bone (GCTB) with denosumab: a two institutions 8-year experience. (2016) (1)
- [Neoadjuvant chemotherapy in malignant fibrous histiocytoma of the extremities. Preliminary results in 10 cases treated preoperatively with methotrexate and cisplatin]. (1987) (1)
- Surgery of Lung Metastases of Osteosarcomas (1991) (1)
- Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone (2016) (1)
- BISPHOSPHONATE TREATMENT OF GIANT CELL TUMOUR OF BONE (2011) (1)
- Erratum to: Osteosarcoma follow-up: chest X-ray or computed tomography? (2017) (1)
- Case report 301. Diagnosis: dedifferentiated chondrosarcoma of the upper end of the humerus. (1985) (1)
- Vertebral histiocytosis. (1990) (1)
- Lung metastasectomy for osteosarcoma in children, adolescents, and young adults: proof of permanent cure (2021) (1)
- Antiproliferative effect of mTOR inhibitor everolimus (EV) alone or in combination with multikinase inhibitor (MK-I) sorafenib (SOR) in preclinical models of osteosarcoma (OS). (2010) (1)
- The influence of preoperative chemotherapy in the surgical planning in patients with osteosarcoma. A study of 205 patients (1990) (1)
- High dose chemotherapy with peripheral blood stem cell (P.B.S.C.) rescue in metastatic Ewing's sarcoma at diagnosis (2005) (1)
- Growth factors contained in platelets enhance proliferation of human mesenchymal stem cells (2002) (1)
- Fibular autograft for distal radius resection (1983) (1)
- Relationship of CUL4A gene underexpression and prognosis in localized high-risk soft tissue sarcoma (STS) patients of limbs or trunk wall. (2012) (1)
- Characterization of tumor microenvironment in extraskeletal myxoid chondrosarcoma (EMC). (2018) (1)
- Erratum: "Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma" (Histology and Hispathology (2004) vol. 19 (2) (401-411)) (2004) (1)
- Additional methods of diagnosis in the histopathology of the musculoskeletal system. (1995) (1)
- Tumor response assessment by Choi criteria in localized high-risk soft tissue sarcoma (STS) treated with chemotherapy (CT): Update at 10-year follow-up of an exploratory analysis on a phase III trial. (2016) (1)
- Efficacy of dose intensification in induction therapy for localized Ewing sarcoma: Italian Sarcoma Group (ISG) and Associazione Italiana Ematologia ed Oncologia Pediatrica (AIEOP) ISG/AIEOP EW-1 study. (2021) (1)
- Soft tissue and visceral sarcomas (1)
- The Role of Resection and Reconstruction in the Treatment of Bone Tumors (1984) (1)
- Tumor response and outcome in localized high-risk soft tissue sarcomas (STS) treated with preoperative chemotherapy (CHT) with or without radiation therapy (RT) within a phase III trial from the Italian Sarcoma Group (ISG) and the Spanish Sarcoma Group (GEIS). (2011) (1)
- Angiosarcoma of bone: A European Muscoloskeletal Oncology Society (EMSOS) multicenter, retrospective study. (2019) (1)
- From a 16th century monastery to a 21st century orthopaedic hospital (2006) (1)
- Total body bone scan in the evaluation of tumor response to preoperative chemotherapy in the treatment of osteosarcoma. (1990) (1)
- P03-13 Preclinical effectiveness of metformin in Ewing sarcoma (2012) (0)
- Growth patterns in chondrosarcoma (1991) (0)
- SARCOMA DEVELOPMENT AFTER CURETTAGE AND BONE GRAFTS OF BENIGN BONE LESIONS (2012) (0)
- OR8-6: The anti-IGF signaling agents increase the efficacy of Trabectedin in Ewing sarcoma (2014) (0)
- Prognostic F actors i n N onmetastatic E wing's S arcoma o f Bone T reated W ith A djuvant C hemotherapy: A nalysis o f 359 P atients a t t he I stituto O rtopedico R izzoli (2000) (0)
- CD99: A new mediator of osteoblastogenesis (2011) (0)
- 340 Effectiveness of a novel, selective inhibitor of the IGF-IR kinase against musculoskeletal tumors (2004) (0)
- Bone metastasis from primary carcinomas and sarcomas: Cell signaling kinase modulation by the neuroreticular axis (2011) (0)
- miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma (2016) (0)
- Abstract 4871: Whole-exome sequencing identifies a high frequency of germline deleterious variants in cancer predisposition genes in individuals with osteosarcoma (2017) (0)
- Secondary peripheral chondrosarcoma of bone - Long term follow-up cases (1991) (0)
- Chondrosarcoma: The Rizzoli Institute experience (1991) (0)
- Antitumor activity of sorafenib in osteosarcoma (OS) preclinical models (2008) (0)
- Preclinical development of sunitinib and nivolumab in osteosarcoma and synovial sarcoma: In vitro functional studies. (2018) (0)
- Up-front melphalan in Ewing's family tumors with bone/bone marrow metastases at onset (very-high risk EFTs). A report from ISG/AIEOP "Very High Risk EFTs Cooperative Study". (2004) (0)
- Abstract 2239: Bone metastasis protein signaling pathway mapping in seven primary tumor types via Reverse Phase Protein Microarray (2010) (0)
- P-glycoprotein Expression in Osteosarcoma: A Basis for Risk-adapted Adjuvant Chemotherapy (2000) (0)
- Prognostic significance of pretreatment serum lactate dehydrogenase (LDH) in patients with osteosarcoma of the extremities (1989) (0)
- Evaluation of quality of life in patients treated with resection and reconstruction of the upper or lower limb for bone sarcomas. (2010) (0)
- Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility (2018) (0)
- Genome-wide association study identifies novel loci associated with osteosarcoma (2013) (0)
- Classification of Primary Bone Tumors (2014) (0)
- Abstract 5196: Different miRNAs expression in leiomyosarcoma and undifferentiated pleomorphic sarcoma (2014) (0)
- Periacetabular resection: the Rizzoli Institute experience (1985) (0)
- Osteosarcoma in patients over 65 years old (2016) (0)
- Pelvic resection: Rizzoli Institute experience (1990) (0)
- Angiosarcoma of bone: a retrospective study of the European Musculoskeletal Oncology Society (EMSOS) (2020) (0)
- Abstract 2894: Integrated bioinformatic analysis to elucidate molecular mechanisms associated with reversal of osteosarcoma malignancy induced by CD99. (2013) (0)
- Integrated approaches to miRNAs target definition: time-series analysis in an osteosarcoma differentiative model (2015) (0)
- Superior Survival of Ewing Sarcoma Family of Tumor Patients Associates With High Expression of C5 at Tumor Site (2009) (0)
- The value of the serum lactic acid dehydrogenase (LDH) level as a prognostic factor in localized Ewing's sarcoma (1983) (0)
- Oncogene alterations in human bone tumors (1996) (0)
- CLINICAL PRACTICE GUIDELINES Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up † (2018) (0)
- Abstract 728: Molecular mechanisms of resistance to anti-IGF-1R therapies in Ewing's sarcoma (2011) (0)
- OP-ANNO180096 51..67 (2018) (0)
- 440: Genomic copy number changes and the prognostic impact of the encoded genes PTEN and BIRC5 in malignant peripheral nerve sheath tumours (2014) (0)
- Abstract 167: Identification of miR-34a as a prognostic biomarker of Ewing sarcoma family of tumors (2011) (0)
- Resections of pelvic bones (1983) (0)
- Resections of the sacrum (1983) (0)
- Case Report 301 (2004) (0)
- Identification of genomic imbalances in methotrexate-resistant human osteosarcoma cell lines (2004) (0)
- The evolution of integrated treatment of soft tissue sarcoma at the Rizzoli Orthopaedic Institute. (2004) (0)
- Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysis (2022) (0)
- 546 POSTER Prognostic value of CCN3 in osteosarcoma and Ewing's sarcoma (2007) (0)
- [Neoadjuvant treatment of osteosarcoma and malignant fibrous histiocytoma of the bones of the extremities: preliminary results in 76 cases treated preoperatively with a methotrexate and cisplatin combination]. (1985) (0)
- Resection of pulmonary metastases in patients with localized Ewing's sarcoma. Report of four cases (1988) (0)
- Abstract 5180: The neuroreticular axis modulates cell signaling kinases in bone metastasis (2011) (0)
- "Limb Sparing Versus Amputation in Osteosarcoma: Istitute Rizzoli Experience" (1991) (0)
- 2.O.09 A EUROPEAN TREATMENT PROTOCOL FOR BONE SARCOMA IN PATIENTS OLDER THAN 40 YEARS (2010) (0)
- Staging and Treatment of Primary Spine Tumors (2000) (0)
- Combined treatment in Ewing's sarcoma (1983) (0)
- Does MGMT (O6-methylguanine–DNA methyltransferase) have a role in metastatic Ewing sarcoma (ES) patients (pts) undergoing temozolomide (TMZ) and irinotecan (IRI)? (2017) (0)
- Abstract 421: Potential biomarkers for monitoring therapy with Denosumab in patients affected by giant cell tumor of bone (2019) (0)
- Adjuvant chemotherapy (AC) with adriamycin (ADM) and high and moderate dose of methotrexate (MTX) for osteosarcoma of the extremities (OSE): an evaluation of results and comparison with concurrent group treated with surgery (1985) (0)
- Pelvic Resection in Bone Sarcomas (1988) (0)
- Abstract 671: Triggering of CD99 induces apoptosis of Ewing's sarcoma cells through activation of p53 functions (2010) (0)
- Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab (2021) (0)
- Value o f P -Glycoprotein a nd C linicopathologi c F actors a s t he Basis f or N ew T reatment S trategies i n H igh-Grade Osteosarcoma o f t he E xtremities (2003) (0)
- Case report 517. Mesenchymal chondrosarcoma of the femur. (1989) (0)
- Postrelapse S urvival i n O steosarcoma o f t he E xtremities: Prognostic F actors f or L ong-Term S urvival (2003) (0)
- Chordomatosis: A very rare but useful to recognise entity (2010) (0)
- Abstract 481: Dualistic regulation of NF-kB signaling by CD99 and EWS-FLI1 in Ewing sarcoma: impact on cell differentiation (2014) (0)
- 3.O.04 HEMANGIOENDOTELIOMA OF BONE: A REVIEW OF THE RIZZOLI EXPERIENCE (2010) (0)
- [Iterative pulmonary metastasis. Considerations on 28 surgically treated cases]. (1989) (0)
- R43How a Clinical Trial Office can improve the independent Clinical Research: the Italian Sarcoma Group experience (2015) (0)
- Abstract 5340: Regulation of osteoblast differentiation: The pivotal role of CD99 molecule (2011) (0)
- Prognostic and therapeutic targets in the " Ewing " family tumours (2008) (0)
- The role of basic research in clinical treatment of Ewing's sarcoma and osteosarcoma. (2003) (0)
- Abstract 2079: Collection of patient-derived xenografts (PDX) to study the biology and therapy of bone sarcomas (2018) (0)
- Abstract 3877: A new frontier for molecular profiling of neoplastic bone tissue (2016) (0)
- [Osteogenic sarcoma: can postoperative chemotherapy be shortened and changed according to the importance of necrosis induced by the preoperative treatment?]. (1986) (0)
- Molecular and Cellular Pathobiology Suppression of Deacetylase SIRT 1 Mediates Tumor-SuppressiveNOTCHResponse andOffers aNovel Treatment Option in Metastatic Ewing Sarcoma (2014) (0)
- Bone Autografting and Allografting in Large Skeletal Resection due to Tumor Resection (1989) (0)
- Neoadjuvant Chemotherapy for Nonmetastatic Osteosarcoma (2006) (0)
- Primary Malignant Peripheral Nerve Sheath Tumors of Bone: A Clinicopathologic Reappraisal of 8 Cases. (2022) (0)
- [Staging, therapy and prognosis of non-Hodgkin's primary lymphoma of bone (or bone reticulosarcoma): experience of the Rizzoli Orthopedic Institute in relation to 30 cases treated in the last 10 years]. (1985) (0)
- Mapping protein signal pathway interaction in sarcoma bone metastasis: linkage between rank, metalloproteinases turnover and growth factor signaling pathways (2013) (0)
- Epidemiology of Bone Lesions of the Sacrum (2017) (0)
- 856 Intensified adjuvant chemotherapy for extremity soft tissue sarcomas (STS) (1995) (0)
- Prognostic role of MRP1 in localized high-risk soft tissue sarcoma (STS): Translational research associated to randomized phase III trial (ISG-STS 1001). (2020) (0)
- Tenosynovial giant cell tumor (TGCT)/pigmented villonodular synovitis (PVNS): Outcome of 313 patients before the era of kinase inhibitors. (2012) (0)
- [Association of Paget's disease with metastasis from a prostatic carcinoma in the same bone segment]. (1980) (0)
- ANALYSIS OF EXT1 AND EXT2 GENES IN PATIENTS AFFECTED BY MULTIPLE HEREDITARY EXOSTOSES: IMPACT ON PHENOTYPE AND SECONDARY CHONDROSARCOMA DEVELOPMENT (2006) (0)
- MicroRNA espression in human and canine osteosarcoma: biomolecular and comparative studies. (2013) (0)
- Six drugs induction chemotherapy for patients with localised Ewing sarcoma (ES): A pilot study. (2006) (0)
- Nerve Sheath Tumor (2019) (0)
- 1439PFDG PET/CT IN PATIENTS TREATED WITH NEOADJUVANT CHEMOTHERAPY FOR LOCALIZED BONE SARCOMAS. (2014) (0)
- Smooth and Striated Muscle (2019) (0)
- Alliance Against Cancer, the network of Italian cancer centers bridging research and care (2015) (0)
- Chordoma of the mobile spine: A retrospective analysis on 146 patients from two reference centers. (2009) (0)
- Original Article Tissue and serum IGFBP7 protein as biomarker in high-grade soft tissue sarcoma (2015) (0)
- 134 Dissecting the mTOR pathway in osteosarcoma (2010) (0)
- Giant Cell Tumour of Bone: The Extracellular Matrix Integrity Plays A Critical Role In Its Biology And Clinical Behaviour (2011) (0)
- Abstract 2534: miRNA expression as potential biomarker for synovial sarcoma (2017) (0)
- 4.O.08 LATE SIDE EFFECTS OF NEOADJUVANT CHEMOTHERAPY AND RADIOTHERAPY IN PATIENTS WITH LOCALIZED EWING’ SARCOMA (2010) (0)
- Sarcomas of the soft tissues. Thirteen years of experience at the Rizzoli Orthopaedic Institute. (2004) (0)
- PO-340 Dysregulation of the TP53 network and PRC2 activity are independent poor prognostic factors in patients with malignant peripheral nerve sheath tumours (2018) (0)
- Hereditary Background in Bone and Soft-Tissue Tumours (2002) (0)
- [Indications and results of the surgical therapy of pulmonary metastasis]. (1987) (0)
- A SIMPLE PROGNOSTIC SCORING SYSTEM FOR NON METASTATIC OSTEOSARCOMA OF THE EXTREMITY (2012) (0)
- Preoperative chemotherapy with methotrexate and cis-diammine-dichloro-platinum II in osteosarcoma (1985) (0)
- Activity of front-line window therapy with temozolomide plus irinotecan in patients with primary multifocal Ewing sarcoma: ISG/AIEOP EW-2 protocol. (2020) (0)
- Fibroblastic/Myofibroblastic Tumors (2019) (0)
- Preoperative chemotherapy in osteosarcoma. Local results and histological evaluation of necrosis in a pilot study including 97 patients (1985) (0)
- Neo-adjuvant Chemotherapy for Osteosarcoma of the Extremities: The Experience at the Rizzoli Institute in 210 Patients Treated with Two Successively Activated Preoperative Protocols Using High-Dose or Moderate-Dose Methotrexate + Cisplatin or High-Dose Methotrexate + Cisplatin + Doxorubicin (1990) (0)
- Abstract LB-366: Everolimus (EV) potentiates Sorafenib (SOR)activity in osteosarcoma (OS) preclinical models: a combination targeting the crosstalk between ERK1/2 and mTORC1/2 signaling pathways (2012) (0)
- Abstract 2970: Multiple new susceptibility loci identified in genome-wide association study of Ewing sarcoma (2018) (0)
- Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial) (2022) (0)
- 3.P.06 HAEMANGIOPERICYTOMA OF BONE: REAL OR IMAGINED? (2010) (0)
- Undifferentiated Pleomorphic Sarcoma (UPS) (2014) (0)
- Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation (2019) (0)
- Whole Lung Irradiation after High-Dose Busulfan/Melphalan in Ewing Sarcoma with Lung Metastases: An Italian Sarcoma Group and Associazione Italiana Ematologia Oncologia Pediatrica Joint Study (2021) (0)
- Cyclin expression and distribution in osteosarcoma (1997) (0)
- Abstract 2077: Genome-wide association study identifies theGLDC/IL33locus associated with survival of osteosarcoma patients (2018) (0)
- Distinguishing Benign Notochordal Cell Tumor from Chordoma (2012) (0)
- Dose intensity and prognosis in the neoadjuvant chemotherapy of osteosarcoma. A retrospective analysis (1991) (0)
- European Musculo-Skeletal Oncology Society Meeting, 4 & 5 May 2000, London: Abstracts and Poster Presentations and Nurses Symposium (2001) (0)
- Prosthetic replacement for bone tumors of the proximal humerus (1986) (0)
- A new randomized trial for the treatment of soft tissue sarcomas of the extremities in adults. Definition of the protocol and preliminary results (1984) (0)
- CHARACTERISATION OF RARE CHONDROSARCOMA SUBTYPES (2012) (0)
- 3.P.12 MORPHOLOGICAL AND IMMUNOPHENOTYPIC FEATURES OF METASTATIC GIANT CELL TUMOURS OF BONE: CLUES TO PATHOGENESIS (2010) (0)
- Neoadjuvant chemotherapy for osteosarcoma. A study on 93 cases (1986) (0)
- Neoadjuvant chemotherapy for osteosarcoma. The experience of the Istituto Ortopedico Rizzoli (IOR) in 112 localized cases (1987) (0)
- [Osteosarcoma of the fibula: study of 20 cases]. (1988) (0)
- Abstract 2946: Effects of two novel quinoline-based non-nucleoside DNA methyltransferase inhibitors against bone sarcomas (2015) (0)
- c-kit Receptor E xpression i n E wing's S arcoma: L ack o f Prognostic V alue b ut T herapeutic T argeting O pportunities i n Appropriate C onditions (2003) (0)
- 1.P.07 OSTEOSARCOMA IN RETINOBLASTOMA SURVIVORS: MOLECULAR ANALYSIS AND RESULTS OF MULTIMODAL MANAGEMENT (2010) (0)
- Prognostic Relevance of CCN3 in Bone Sarcomas (2010) (0)
- Response to the letter by Dr Klein (2009) (0)
- Serum alkaline phosphatase monitoring in the evaluation of non-metastatic osteosarcoma response of the extremities to preoperative chemotherapy. Study of 180 cases (1989) (0)
- [The role of surgery in treatment of non-metastatic Ewing's sarcoma. Experience of the Rizzoli Orthopedic Institute in 163 cases]. (1981) (0)
- Abstract 3406: Prognostic relevance of Wnt-beta catenin signaling in Ewing's sarcoma (2010) (0)
- Autologous Peripheral Blood Stem Cell Transplantation in Childhood Metastatic Osteosarcoma (2000) (0)
- MR imaging of osteosarcoma (1991) (0)
- Working Party Solid Tumours (2001) (0)
- Endoprostheses and arthroprostheses for resection of the proximal femur (1983) (0)
- Telangiectatic Osteogenic Sarcoma of the Extremities (2006) (0)
- TFE3 Expression and Rearrangement in Epithelioid Vascular Tumors (2015) (0)
- HMGA 1 / E 2 F 1 AXIS AND NFKB PATHWAYS REGULATE LIPOSARCOMA PROGRESSION AND TRABECTEDIN RESISTANCE (2017) (0)
- Adjuvant C hemotherapy f or A dult S oft T issue S arcomas o f the E xtremities a nd G irdles: R esults o f t he I talian Randomized C ooperative T rial (2001) (0)
- Tumor cell NG2 proteoglycan controls cancer progression through its interaction with host Collagen type VI (2008) (0)
- Endoprostheses for resections of the proximal humerus (1983) (0)
- Preoperative chemotherapy by intra-arterial infusion for osteosarcoma of the extremities. Local results of a pilot study including 50 patients (1984) (0)
- Abstract A42: miR34a: A valuable indicator of differential outcome of Ewing sarcoma patients with complex functions (2014) (0)
- C02High-grade bone sarcomas with synchronous metastases in patients older than 40. Results of the European Bone over 40: Sarcoma Study (EURO.B.O.S.S.) (2015) (0)
- Abstract 590: Identification and validation of novel candidate circulating biomarkers in high-grade soft tissue sarcoma (2015) (0)
- Temozolamide and irinotecan in metastatic Ewing sarcoma: An Italian Sarcoma Group and Royal Marsden Hospital join study. (2016) (0)
- Small Cell Osteosarcoma (2014) (0)
- A new randomized trial for treatment of soft tissue sarcomas of the extremities in adult patients (1986) (0)
- Palliative treatments: Selective arterial embolization for bone metastases (2012) (0)
- ABCB1/P-glycoprotein (Pgp) expression as stratification factor for treatment of patients with non-metastaticextremity high-grade osteosarcoma: A merged analysis of an Italian (ISG) and a Spanish (GEIS) sarcoma groups' multicentric prospective trials. (2021) (0)
- High-Grade Osteosarcoma of the Surface (2014) (0)
- An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas (2014) (0)
- Adjuvant and neoadjuvant chemotherapy for malignant fibrous histiocytoma of bone of the extremity (1987) (0)
- Tumoral or traumatic musculoskeletal lesions: not always so easy (2011) (0)
- Abstract 1969: miRNA expression as potential biomarker for leiomyosarcoma and undifferentiated pleomorphic sarcoma (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Piero Picci?
Piero Picci is affiliated with the following schools:
